Gideon Meyerowitz‐Katz

3.5k total citations · 2 hit papers
37 papers, 1.6k citations indexed

About

Gideon Meyerowitz‐Katz is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Gideon Meyerowitz‐Katz has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Infectious Diseases and 9 papers in Modeling and Simulation. Recurrent topics in Gideon Meyerowitz‐Katz's work include COVID-19 epidemiological studies (9 papers), COVID-19 and healthcare impacts (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Gideon Meyerowitz‐Katz is often cited by papers focused on COVID-19 epidemiological studies (9 papers), COVID-19 and healthcare impacts (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Gideon Meyerowitz‐Katz collaborates with scholars based in Australia, United States and United Kingdom. Gideon Meyerowitz‐Katz's co-authors include Lea Merone, Andrew Levin, Nana Owusu‐Boaitey, Seamus P. Walsh, William P. Hanage, Glen Maberly, Thomas Astell‐Burt, Sumathy Ravi, Xiaoqi Feng and Leonard Arnolda and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Hypertension.

In The Last Decade

Gideon Meyerowitz‐Katz

33 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

2020 497 citations Andrew Levin, William P. Hanage et al. European Journal of Epidemiology profile →
Rates of Attrition and Dropout in App-Based Interventions for Chronic Disease: Systematic Review and Meta-Analysis

2020 290 citations Gideon Meyerowitz‐Katz, Sumathy Ravi et al. Journal of Medical Internet Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gideon Meyerowitz‐Katz Australia	14	539	496	360	231	213	37	1.6k
Shahul H. Ebrahim United States	24	398 0.7×	417 0.8×	406 1.1×	126 0.5×	478 2.2×	74	2.4k
Monica Webb Hooper United States	19	378 0.7×	258 0.5×	749 2.1×	436 1.9×	408 1.9×	83	2.7k
Nia Reed United States	4	742 1.4×	297 0.6×	179 0.5×	377 1.6×	105 0.5×	7	1.6k
Farida Ahmad United States	16	343 0.6×	192 0.4×	327 0.9×	463 2.0×	151 0.7×	25	1.8k
David Benkeser United States	18	370 0.7×	191 0.4×	297 0.8×	191 0.8×	164 0.8×	66	1.8k
Nina Gobat United Kingdom	17	196 0.4×	216 0.4×	288 0.8×	149 0.6×	166 0.8×	57	1.1k
Chang Sun China	6	665 1.2×	333 0.7×	144 0.4×	205 0.9×	90 0.4×	17	1.6k
Pierre Arwidson France	16	400 0.7×	276 0.6×	168 0.5×	74 0.3×	95 0.4×	54	1.3k
Sasmita Poudel Adhikari United States	5	665 1.2×	332 0.7×	136 0.4×	204 0.9×	85 0.4×	8	1.6k
Daniel Fort United States	13	619 1.1×	187 0.4×	291 0.8×	468 2.0×	151 0.7×	46	1.6k

Countries citing papers authored by Gideon Meyerowitz‐Katz

Since Specialization

Citations

This map shows the geographic impact of Gideon Meyerowitz‐Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gideon Meyerowitz‐Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gideon Meyerowitz‐Katz more than expected).

Fields of papers citing papers by Gideon Meyerowitz‐Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gideon Meyerowitz‐Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gideon Meyerowitz‐Katz. The network helps show where Gideon Meyerowitz‐Katz may publish in the future.

Co-authorship network of co-authors of Gideon Meyerowitz‐Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Gideon Meyerowitz‐Katz. A scholar is included among the top collaborators of Gideon Meyerowitz‐Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gideon Meyerowitz‐Katz. Gideon Meyerowitz‐Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, Julia K., Katie Wynne, C. Kenneth McAllister, et al.. (2025). Cass Review does not guide care for trans young people. The Medical Journal of Australia. 223(7). 331–337. 1 indexed citations

Meyerowitz‐Katz, Gideon, et al.. (2025). Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist and aspirin co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study. Diabetes Obesity and Metabolism. 27(4). 1980–1991. 1 indexed citations

Ravi, Sumathy, Gideon Meyerowitz‐Katz, Julie Ayre, et al.. (2025). Effect of virtual care in type 2 diabetes management – a systematic umbrella review of systematic reviews and meta-analysis. BMC Health Services Research. 25(1). 348–348. 1 indexed citations

Huang, Yu‐Nan, et al.. (2025). Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity. Communications Medicine. 5(1). 329–329.

Meyerowitz‐Katz, Gideon, et al.. (2024). Integrating point-of-care diabetes detection with lifestyle counselling in community settings: outcomes from Western Sydney, Australia. BMC Health Services Research. 24(1). 926–926. 1 indexed citations

Meyerowitz‐Katz, Gideon, et al.. (2023). Diabetes during the COVID-19 pandemic: are people getting access to the right level of care?. BMC Health Services Research. 23(1). 167–167. 5 indexed citations

Owusu‐Boaitey, Nana, Timothy Russell, Gideon Meyerowitz‐Katz, Andrew Levin, & Daniel Herrera. (2023). Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study. Eurosurveillance. 28(21). 5 indexed citations

Dunn, Hamish, Adrian T. Fung, Glen Maberly, et al.. (2023). Diabetic Retinopathy Screening at the Point of Care (DR SPOC): detecting undiagnosed and vision-threatening retinopathy by integrating portable technologies within existing services. BMJ Open Diabetes Research & Care. 11(4). e003376–e003376. 5 indexed citations

Levin, Andrew, Nana Owusu‐Boaitey, Bailey K. Fosdick, et al.. (2022). Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. 7(5). e008477–e008477. 115 indexed citations

10.

Nickel, Brooke, Kristen Pickles, Erin Cvejic, et al.. (2022). Predictors of confidence and trust in government and institutions during the COVID-19 response in Australia. The Lancet Regional Health - Western Pacific. 23. 100490–100490. 13 indexed citations

11.

Besançon, Lonni, Elisabeth M. Bik, James Heathers, & Gideon Meyerowitz‐Katz. (2022). Correction of scientific literature: Too little, too late!. PLoS Biology. 20(3). e3001572–e3001572. 23 indexed citations

12.

Zheng, Yu, et al.. (2022). Evaluating the Effectiveness of Joint Specialist Case Conferences in Improving Diabetes Control in Patients With Schizophrenia on Clozapine. The Journal of Nervous and Mental Disease. 211(3). 221–225. 1 indexed citations

13.

Meyerowitz‐Katz, Gideon, Lonni Besançon, Antoine Flahault, & Raphael Wimmer. (2021). Impact of mobility reduction on COVID-19 mortality: absence of evidence might be due to methodological issues. Scientific Reports. 11(1). 23533–23533. 4 indexed citations

14.

Isautier, Jennifer, Tessa Copp, Julie Ayre, et al.. (2020). People’s Experiences and Satisfaction With Telehealth During the COVID-19 Pandemic in Australia: Cross-Sectional Survey Study. Journal of Medical Internet Research. 22(12). e24531–e24531. 157 indexed citations

15.

Meyerowitz‐Katz, Gideon, Sumathy Ravi, Leonard Arnolda, et al.. (2020). Rates of Attrition and Dropout in App-Based Interventions for Chronic Disease: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 22(9). e20283–e20283. 290 indexed citations breakdown →

16.

Meyerowitz‐Katz, Gideon & Lea Merone. (2020). A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. International Journal of Infectious Diseases. 101. 138–148. 262 indexed citations

17.

Levin, Andrew, et al.. (2020). Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. European Journal of Epidemiology. 35(12). 1123–1138. 497 indexed citations breakdown →

18.

Meyerowitz‐Katz, Gideon, et al.. (2019). The effect of an mHealth intervention for titration of insulin for type 2 diabetes: A pilot study. European Journal of Cardiovascular Nursing. 19(5). 386–392. 9 indexed citations

19.

Meyerowitz‐Katz, Gideon, Pankaj Gaur, Thomas Astell‐Burt, et al.. (2019). Detecting the hidden burden of pre-diabetes and diabetes in Western Sydney. Diabetes Research and Clinical Practice. 151. 247–251. 8 indexed citations

20.

Meyerowitz‐Katz, Gideon, Sumathy Ravi, Xiaoqi Feng, et al.. (2018). Effectiveness of joint specialist case conferences for building general practice capacity to enhance diabetes care. Journal of Integrated Care. 26(3). 199–210. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact